PEN Penumbra, Inc.
$324.04▼ -0.36%
Healthcare
Other
Volume 407.2K
Avg Volume (10D) 339.1K
Key Metrics & Fundamentals
Market Cap
$12.76B
P/E Ratio
79.8
Div Yield
0.00%
52W Range
221.26 - 362.41
% vs 50 MA
1.00%
% vs 200 MA
-1.01%
RSI-14
60.7
MACD Histogram
+0.5800
Beta (1Y vs SPY)
0.06
Free Cash Flow
$32.54M
Gross Rev
$390.05M
Gross Profit
$264.94M
EBITDA
$52.11M
COGS
$125.10M
Operating Exp
$223.91M
Operating Income
$41.04M
EBIT
$41.04M
Pretax Income
$46.19M
Net Income
$34.81M
EPS (Diluted)
0.88
Price & Volume History
Loading chart…
Recent News

Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
PR Newswire · Oct 20, 2026 9:00 AM ET

Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus
Simply Wall St. · Oct 8, 2026 12:20 PM ET
Boston Scientific names Joseph Fitzgerald as chief operating officer
MedTech Dive · Oct 8, 2026 6:55 AM ET

New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
PR Newswire · Oct 6, 2026 9:00 AM ET

IART vs. PEN: Which Stock Is the Better Value Option?
Zacks · Oct 1, 2026 10:40 AM ET

IART or PEN: Which Is the Better Value Stock Right Now?
Zacks · Sep 29, 2026 10:40 AM ET

Reasons to Retain Penumbra Stock in Your Portfolio for Now
Zacks · Sep 16, 2026 9:13 AM ET

TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks · Sep 11, 2026 11:40 AM ET

TFX or PEN: Which Is the Better Value Stock Right Now?
Zacks · Aug 26, 2026 11:40 AM ET

Which Medtech Giant Would Buy Inspire Medical Systems?
Trefis · Aug 14, 2026 5:54 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PEN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.